Ba Xuan Hoang

Ba Xuan Hoang, MD, PhD, is an Assistant Professor of Research Surgery at the University of Southern California's School of Medicine. His research focuses on cancer biology, regenerative medicine, and drug development, with a particular emphasis on pancreatic cancer, osteosarcoma, and therapeutic strategies involving exosomes and nanomaterials. He has pioneered work on the SCFSkp2 E3 ubiquitin ligase pathway in prostate tumorigenesis and developed the scDAPP single-cell transcriptomics analysis pipeline. His studies also explore socioeconomic disparities in cancer care access and outcomes.

Research interests include anticancer drug efficacy, redox signaling pathways, and biomaterials for modulating immune and inflammatory responses. He investigates natural health supplements for pain management and musculoskeletal conditions, alongside preclinical evaluations of novel compounds like Nowarta110 and fenbendazole for cancer treatment. His work bridges molecular mechanisms with translational applications, including surgical techniques for metastatic bone lesions and 3D tissue models for metastasis dynamics.

Notable contributions span over 100 peer-reviewed publications, covering topics from zinc-based therapies to bioenergetic approaches in cancer prevention. His interdisciplinary approach integrates genomics, bioinformatics, and clinical trials to address unmet needs in oncology and regenerative medicine.